FDA Narrows COVID-19 Vaccine Approval for Younger Populations
Published on: Aug. 28, 2025, 12:38 a.m. | Source: Devdiscourse
The FDA narrowed its approval for COVID-19 vaccines, focusing on high-risk groups under 65 while maintaining access for those over 65. The move marks a shift from previous years where vaccines were broadly available, sparking concerns about coverage and access under new health policy directions.
